Anshu Marathe

Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions

Joo Yeon Lee, Christine Garnett, Jogarao Gobburu et al. · Clinical Pharmacokinetics · 2011 · 148 citations

Pharmacy, Pharmaceutical Policy, Pharmacology +9

Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary

Katherine A. Thornton, Geoffrey Kim, V. Ellen Maher et al. · Clinical Cancer Research · 2012 · 147 citations

Medicine, Oncology, Pharmacology +7

U.S. Food and Drug Administration Approval: Crizotinib for Treatment of Advanced or Metastatic Non–Small Cell Lung Cancer That Is Anaplastic Lymphoma Kinase Positive

Shakun Malik, V. Ellen Maher, Karen E. Bijwaard et al. · Clinical Cancer Research · 2014 · 139 citations

Medicine, Oncology, Pharmacology +14

FDA Approval Summary: Lenvatinib for Progressive, Radio-iodine–Refractory Differentiated Thyroid Cancer

Abhilasha Nair, Steven J. Lemery, Jun Yang et al. · Clinical Cancer Research · 2015 · 78 citations

Medicine, Oncology, Pharmacology +15

Integrated Cellular Bone Homeostasis Model for Denosumab Pharmacodynamics in Multiple Myeloma Patients

Anshu Marathe, Mark Peterson, Donald E. Mager · Journal of Pharmacology and Experimental Therapeutics · 2008 · 76 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17